SNES - SenesTech, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
0.6000
-0.0100 (-1.64%)
As of 9:37AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close0.6100
Open0.6000
Bid0.6000 x 900
Ask0.6400 x 800
Day's Range0.5900 - 0.6000
52 Week Range0.5500 - 1.9500
Volume46,973
Avg. Volume139,020
Market Cap17.397M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.3970
Earnings DateNov 12, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.68
  • SNES: Encouraging quarterly earnings results. Expect an uptick in sales in 2020.
    Zacks Small Cap Research

    SNES: Encouraging quarterly earnings results. Expect an uptick in sales in 2020.

    NASDAQ:SNES (Source: Shutterstock) Leptospira is a bacterium that is transmitted by rats to humans. As per CDC, contracting Leptospirosis can cause illness and when left untreated can lead to respiratory distress, kidney damage, liver failure and death. Some of the “rattiest” cities in the U.S. are New York, Washington D.C., Los Angeles, Chicago and San Francisco, to name a few. Rat infestations

  • Zacks Small Cap Research

    SNES: Results for the Washington DC project are very encouraging. ContraPest deployment in San Francisco and Los Angeles have been initiated. 2Q19 financials were close to our expectations.

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT On Nov. 12, 2019, SenesTech (NASDAQ:SNES) reported its third quarter results. In general the numbers were in line with our estimates with revenue of $0.04 million (Est. $0.04 million) and, adjusted for non reoccurring professional and legal fees, the operating loss was $2.4 million (est. $2.1 million). The company is

  • PR Newswire

    SenesTech Announces Third Quarter 2019 Financial and Operational Results

    FLAGSTAFF, Ariz. , Nov. 12, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced ...

  • PR Newswire

    SenesTech Announces Update on Washington DC ContraPest® Deployment

    FLAGSTAFF, Ariz., Nov. 12, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today positive progress on current deployment and site updates for fertility control in the city of Washington DC. "SenesTech agreed to provide a camera to DC Health in August 2019 to obtain information on how the rat populations in an alley in Adams Morgan was responding to ContraPest," said Brandy Pyzyna, Vice President of Scientific Operations.

  • PR Newswire

    SenesTech, Inc. to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019

    FLAGSTAFF, Ariz., Nov. 5, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its third quarter of 2019, ended September 30, 2019, after the market close on Tuesday, November 12, 2019. The Company has scheduled a conference call that same day, Tuesday, November 12, 2019, at 5:00 pm ET, to review the results. Call-in Information: Interested parties can access the conference call by dialing (844) 308-3351 or (412) 317-5407.

  • Read This Before Selling SenesTech, Inc. (NASDAQ:SNES) Shares
    Simply Wall St.

    Read This Before Selling SenesTech, Inc. (NASDAQ:SNES) Shares

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...

  • SNES: A 21st century approach to curb rat infestation!
    Zacks Small Cap Research

    SNES: A 21st century approach to curb rat infestation!

    NASDAQ:SNES Background SenesTech Inc., head-quartered in Flagstaff, AZ was founded in 2004. The firm has developed a solution for managing pests through fertility control. Their current marketed product, ContraPest®, a liquid bait, limits fertility in male and female rats. ContraPest is the first and only non-lethal, fertility control product approved by the Environmental Protection Agency (EPA)

  • Zacks Small Cap Research

    SNES: Initiating coverage of SenesTech with a price target of $1.35

    By Ian Gilson, PhD, CFA NASDAQ:SNES READ THE FULL SNES RESEARCH REPORT SenesTech Inc. (NASDAQ:SNES) is in the transition from being a drug discovery company to commercialization of its rodenticide contraceptive, ContraPest. The replacement of second generation anti-coagulant products with alternative treatments would open a multimillion dollar market in the

  • PR Newswire

    SenesTech Expands ContraPest® in Organic Agriculture

    "The organic industry is a natural part of our broader food and agriculture strategy," said Kenneth Siegel, SenesTech's CEO. "As with their conventional counterparts, organic facilities have struggled with rodent management and are looking for effective solutions.  ContraPest, either alone or as part of a broader integrated pest management program, offers them a new alternative that will reduce both product loss and contamination risk.

  • PR Newswire

    ContraPest® Sales Expand in California Agriculture

    FLAGSTAFF, Ariz., Sept. 16, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today regulatory approval for expanded use of ContraPest® in agricultural settings in California, and expanded sales to agricultural customers. The California Certified Organic Farmers (CCOF) has provided approval for ContraPest use at Lundberg Farms, one of the largest organic rice farming operations in the state.

  • PR Newswire

    SenesTech to Present at the 21st Annual Global Investment Conference on September 9, 2019

    FLAGSTAFF, Ariz., Sept. 4, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be presenting at the 21st Annual Global Investment Conference Sponsored by H.C. Wainwright in New York City. The SenesTech presentation will be made by Ken Siegel, CEO, and Tom Chesterman, CFO, on Monday, September 9th at 4:15 pm Eastern Time. A live audio webcast of the H.C. Wainwright Conference presentation can be accessed by visiting 'Events and Presentations' in the Investor Relations section on the Company's website at www.senestech.com or here.

  • PR Newswire

    ContraPest® Deployment in Los Angeles, CA

    FLAGSTAFF, Ariz., Aug. 27, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that the City of Los Angeles, CA will begin implementing ContraPest® into their current IPM programs with their city contracted pest company, Cats USA, at various locations. Cats USA Pest Control provides residential and commercial service throughout Southern California using adaptive and innovative approaches at managing pests. "Our ambition is to provide our customers with effective alternatives to the ever-growing concerns regarding anticoagulant rodenticides," said Michael Hunt, Service Manager of Cats USA.

  • What Kind Of Shareholder Appears On The SenesTech, Inc.'s (NASDAQ:SNES) Shareholder Register?
    Simply Wall St.

    What Kind Of Shareholder Appears On The SenesTech, Inc.'s (NASDAQ:SNES) Shareholder Register?

    Every investor in SenesTech, Inc. (NASDAQ:SNES) should be aware of the most powerful shareholder groups. Insiders...

  • PR Newswire

    SenesTech Announces Second Quarter 2019 Financial and Operational Results

    FLAGSTAFF, Ariz. , Aug. 13, 2019 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced ...

  • Benzinga

    SenesTech's Earnings Outlook

    On Tuesday, August 13, SenesTech (NASDAQ: SNES ) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release. Earnings and Revenue Wall Street ...

  • PR Newswire

    SenesTech, Inc. to Report Second Quarter 2019 Financial Results on Tuesday, August 13, 2019

    FLAGSTAFF, Ariz., Aug. 1, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its second quarter of 2019, ended June 30, 2019, after the market close on Tuesday, August 13, 2019. The Company has scheduled a conference call that same day, Tuesday, August 13, 2019, at 5:00 pm ET, to review the results. Call-in Information: Interested parties can access the conference call by dialing (844) 308-3351 or (412) 317-5407.

  • GuruFocus.com

    Insiders Roundup: Garmin, Dolby

    Largest insider trades of the week Continue reading...

  • GuruFocus.com

    Senestech Inc (SNES) CEO Kenneth S Siegel Bought $940,000 of Shares

    CEO of Senestech Inc (30-Year Financial, Insider Trades) Kenneth S Siegel (insider trades) bought 696,296 shares of SNES on 07/16/2019 at an average price of $1.35 a share. Continue reading...

  • PR Newswire

    SenesTech Announces Closing of Public Offering of Common Stock

    FLAGSTAFF, Ariz., July 17, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that it has closed the public offering of common stock, as was announced on Thursday, July 11, 2019, with gross proceeds of $4.1 million. The offering was common stock only and did not include dilutive warrants. The proceeds allow the Company to fully engage in sales and marketing efforts in California and other target markets.

  • Does Market Volatility Impact SenesTech, Inc.'s (NASDAQ:SNES) Share Price?
    Simply Wall St.

    Does Market Volatility Impact SenesTech, Inc.'s (NASDAQ:SNES) Share Price?

    Anyone researching SenesTech, Inc. (NASDAQ:SNES) might want to consider the historical volatility of the share price...

  • PR Newswire

    SenesTech Announces Pricing of $4.1 Million Public Offering of Common Stock

    FLAGSTAFF, Ariz., July 11, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced  the pricing of its previously announced public offering of 3,037,038 shares of its common stock at a price to the public of $1.35 per share. SenesTech expects to receive aggregate gross proceeds of approximately $4.1 million from the offering. The shares of common stock are being offered by SenesTech pursuant to a "shelf" registration statement on Form S-3 (Registration No. 333-225712) previously filed with and declared effective by the Securities and Exchange Commission (the "SEC") on August 24, 2018.

  • PR Newswire

    SenesTech Announces Proposed Public Offering of Common Stock

    FLAGSTAFF, Ariz., July 11, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that it intends to offer and sell shares of its common stock in a public offering.  The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The shares of common stock are being offered by SenesTech pursuant to a "shelf" registration statement on Form S-3 (Registration No. 333-225712) previously filed with and declared effective by the Securities and Exchange Commission (the "SEC") on August 24, 2018. A preliminary prospectus supplement describing the terms of the offering will be filed with the SEC and will form a part of the effective registration statement.

  • PR Newswire

    California Bill to Ban SGAR Rodenticides Clears Senate Natural Resources & Water Committee

    FLAGSTAFF, Ariz., July 10, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announces that AB 1788, the California Ecosystems Protection Act, has moved into the final stretch for approval with the "do pass" action at the Senate Natural Resources and Water Committee today.  AB 1788, would ban the use of Second Generation Anticoagulant Rodenticides (SGARs) throughout the state of California, with certain exceptions, and would also ban the use of First Generation Anticoagulant Rodenticides (FGARs) on state-owned lands. The high toxicity and persistence of these rat poisons is responsible for the poisoning and contamination of mountain lions, bobcats and hawks and other wildlife that prey on poisoned rats and animals that have consumed the rats.

  • PR Newswire

    SenesTech Joins the Russell Microcap Index

    FLAGSTAFF, Ariz., July 1, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it has been added to the Russell Microcap® Index effective after the market close on Friday, June 28, 2019, as part of the Russell Indexes annual reconstitution. Ken Siegel, Chief Executive Officer of SenesTech, said, "We are extremely pleased to have been selected to join the Russell Microcap Index. FTSE Russell is a leading global index provider creating and managing a wide range of indexes, data and analytic solutions to meet client needs across asset classes, style and strategies.

  • PR Newswire

    California Bill to Ban SGAR Rodenticides Clears Senate Environmental Quality Committee

    FLAGSTAFF, Ariz., June 20, 2019 /PRNewswire/ -- SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announces that AB1788, which will ban the use of Second Generation Anticoagulant Rodenticides (SGARs), has moved another step closer to becoming law. "It was a privilege to be invited to testify before the Senate committee meeting today to support California's consideration of a bill that will propel the state forward in its environmental stewardship.  I was joined by our Vice President of Scientific Operations, Brandy Pyzyna and Dr. Stephen Shuster of Northern Arizona University," said Dr. Loretta Mayer, Chief Scientific Officer and co-Founder of SenesTech.